Documents
A list of downloadable documents created during development.
Background information
Breast cancer - bevacizumab (in combination with a taxane): Equality impact assessment
Breast cancer - bevacizumab (in combination with a taxane): final appraisal determination
-
Breast cancer - bevacizumab (in combination with a taxane): consultee and commentator comments on the ACD
Breast cancer - bevacizumab (in combination with a taxane): appraisal consultation
-
Breast cancer - bevacizumab (in combination with a taxane): appraisal consultation
-
Breast cancer - bevacizumab (in combination with a taxane): evaluation report
-
Breast cancer - bevacizumab (in combination with a taxane): non-manufacturer submissions
-
Breast cancer - bevacizumab (in combination with a taxane): manufacturer submissions
-
Breast cancer - bevacizumab (in combination with a taxane): expert written personal statements